Expanded clinical information website offering now available to PDR members creates new opportunities for M3’s customers in healthcare professional promotion, market research and physician employment.
(Washington, DC, November 18th, 2013) The award winning MDLinx content, (www.mdlinx.com), is now offered as membership benefit to all PDR’s members. Through this tightly integrated partnership with PDR, (www.pdrnetwork.com), M3 is now capable of reaching nearly 600,000 US physicians on behalf of its customers in brand marketing, market research, and physician recruiting.
“PDR is a one-of-a-kind brand, trusted by physicians to deliver highly relevant drug information,” remarked Aki Tomaru, CEO of M3 USA. “MDLinx has been the leading website for U.S. specialty physicians. With the launching of PDR Powered by MDLinx, (mdlinx.pdr.net), M3 adds 330,000 US physicians, significantly extending our reach in key specialties such as primary care, psychiatry, urology and pediatrics. Combined with our existing industry leading coverage in oncology, rheumatology and endocrinology, our HCP reach may be the best to the specialties that matter most to both Pharmaceutical and Life Science companies. This represents a tremendous opportunity for our customers.”
“We are thrilled to partner with MDLinx, as PDR continues to expand our HCP offerings,” comments Rich Altus, President of PDR. “Their practical medical information can now be found right on our site, PDR Powered by MDLinx. This powerful offering will provide even more reasons for prescribers to rely on PDR for the most relevant drug and clinical information inside and outside of workflow.” PDR continues to lead the industry by providing drug information and patient support inside the physician’s Electronic Health Record (EHR).
MDLinx is the most actively used website among HCPs today. Now with the PDR partnership in place, M3 offers the greatest reach in the industry to its customers. This is M3 Group’s second industry leading partnership inked in just over two months, the last being an integration with MMIT, to deliver market access information directly to Healthcare Providers.
“We are committed to helping HCPs get the latest medical information available to help them make the most informed prescribing decisions for their patients,” remarks Tomaru. “The PDR partnership is the next great step in our continued growth strategy in the United States.”
About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 5 million physician members globally via its physician websites such as www.m3.com, www.mdlinx.com, and www.medigate.net. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.
M3 Group Links
mdlinx.pdr.net www.mdlinx.com www.doctors.net.uk www.networksinhealth.com www.thesmartestdoc.com research.m3.com
About PDR Network
PDR Network is the nation’s leading aggregator and distributor of FDA-approved drug safety information and patient support services, reaching healthcare providers directly through the Physicians’ Desk Reference® suite of digital and print services. PDR® Communications provides direct access to more than one million healthcare professionals with both promotional and clinical vehicles. Healthcare professionals access trusted PDR content across channels, including via the Physicians’ Desk Reference (PDR), the most recognized drug information reference available in the U.S., now available in multiple formats; PDR interactive drug services for Electronic Health Record (EHR) systems; PDR.net®, the online home of the PDR; and mobilePDR® for handheld devices. The PDR Pharmacy Discount Card helps patients afford their medications – is a free service to physicians and their patients. For more information on our products and services, please visit www.pdrnetwork.com.
PDR Network Links
www.pdr.net www.pdrnetwork.com http://www.pdr.net/DiscountCard/
The Smartest Doc confirmed as a FINALIST for the Best Healthcare Professional Media Brand in the 2012 MM&M Awards!
We are proud to announce that The Smartest Doc has been confirmed as a FINALIST for the Best Healthcare Professional Media Brand in the 2012 MM&M Awards!
Our product is one of five in this category chosen by a panel of over 100 industry experts. While it’s an honor just to be nominated, we’re hoping to bring home a prestigious Gold or Silver award. We’ll find out the results during the ceremony being held in NYC on October 9.
Wish us luck!
The Smartest Doc has challenges in Internal Medicine, Family Practice, Oncology, Diabetes, Neurology, Pediatrics, Dermatology and Cardiology. Test your clinical acumen and speed, and generates national recognition.
M3 Global Research Announces: “Verified, Certified, Guaranteed” Promise to Research Industry Executives at PBIRG and CASRO Conferences
Chicago, IL and San Antonio, TX (PRWEB) May 17, 2011
M3 Global Research today announced a ground-breaking program intended to revolutionize healthcare professional market research procurement. The new M3 program, “Verified, Certified, Guaranteed” found at http://www.VerifiedCertifiedGuaranteed.com, is the capstone of a five year effort to build and manage the largest, most respected verified and certified panel of healthcare professionals in the world. Recently M3 USA completed the rigorous process to earn ISO certification, which has resulted in significant efficiencies and considerable cost savings in the supply chain process for healthcare professional procurement.
“We started our market research division five years ago with a single vision – to be the premiere and primary source for physician market research around the world, and to provide this service with one-stop-shopping capability, “ said Craig Overpeck, COO of M3 Global Market Research. “Along the way we achieved dual certification by the MRA and ISO, proving beyond doubt that we’re number one in quality and signifying a recognized efficiency in our operations. Now we are ready to transform the way companies procure the physicians for market research.”
M3 Global Research now guarantees to offer the lowest price in professional healthcare market research recruitment provided a project is feasible. Market Research companies will save both time and money by working directly with the acknowledged and trusted market leader. The result for clients is highest quality and the lowest price, guaranteed.
Please email your inquires for professional healthcare sample to firstname.lastname@example.org. You‘ll receive a prompt response from an experienced professional representative who will answer your questions, provide feasibility and field time estimates based on your project specifications. Only clients who submit their RFPs directly to M3 Global Research are eligible for this program.
Karie Eastburn for M3 Global Research
M3 Global Research combines MDLinx and EMS to offer online access to 1.3 million healthcare professionals
Washington, DC, November 22, 2010 – M3 USA, parent company of MDLinx, a leading medical market research firm, has signed an agreement to purchase EU-based EMS Research, a company specializing in quantitative and qualitative market research for clients in healthcare and other vertical markets.
The acquisition creates the largest verified provider of physicians and other healthcare professionals in the world. This new international division will be designated M3 Global Research. With offices in the US, UK, Germany, Japan, Korea and China, M3 Global Research will offer access to 1.3 million verified doctors and other healthcare professionals, differentiated into more than 700 subspecialties.
M3 Global Research will provide the highest standard of direct access, utilizing its proprietary physician panels, online survey tools, call centers, fieldwork studios, and in-house project managers in offices around the world.
“EMS Research has always prided itself on our superior market research capabilities. By teaming with M3, we have greatly expanded the depth and breadth of our abilities on a global perspective,” said Neil Jarvis, Director at EMS.
“Europe was the missing component in our market research global coverage strategy. The EMS acquisition firmly secures our place as the healthcare market research industry leader, and equips us with the largest verified panel of healthcare professionals in the world,” said Aki Tomaru, CEO of M3 USA. “Our clients will now enjoy unparalleled global reach as they gather insights from healthcare professionals and experience our best-in-industry, single source service.”
M3 Global Research and M3 USA
M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professional panel of 1.3 million respondents in more than 60 countries. The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research in Europe, and M3 companies across Asia. M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers. M3 has provided solutions for every top 20 pharmaceutical company in the world. For more information, visit http://research.m3.com or email requests to email@example.com.
EMS Research, headquartered in London, England, was founded in 1999 and is Europe’s leading in-house medical fieldwork company. M3 Global Research will maintain EMS’s unparalleled research quality at competitive cost via effective management and expansion of research assets across Europe, including respondent databases, pan-European project teams, in-house moderators, online survey tools, call centers, field teams and viewing facilities.
Greg Jones for M3 Global Research